DSpace Repository

DBeQ-mediated pharmacological modulation of the retrotranslocation step of ERAD may exhibit a potent therapeutic approach against colorectal cancer

Show simple item record

dc.creator ERZURUMLU, Yalçın
dc.creator Dogan, Hatice Kubra
dc.date 2023-01-01T00:00:00Z
dc.date.accessioned 2025-02-25T10:32:26Z
dc.date.available 2025-02-25T10:32:26Z
dc.identifier 78c4411c-638c-4131-81b7-bc196f75feb1
dc.identifier 10.23893/1307-2080.aps6125
dc.identifier https://avesis.sdu.edu.tr/publication/details/78c4411c-638c-4131-81b7-bc196f75feb1/oai
dc.identifier.uri http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/100226
dc.description The incidence of colorectal cancer is 30% higher in men compared to women. Altho-ugh there are different treatment options for colorectal cancer, including chemot-herapy and immunotherapy, acquired drug resistance and some specific mutations substantially restrict the treatment options. N(2), N(4)-dibenzylquinazoline-2,4-diamine (DBeQ) is a selective and ATP-competitive inhibitor molecule of p97/Va-losin-containing protein (VCP) protein. p97/VCP is a well-conserved and abundant hexameric type II ATPases associated with diverse cellular activities (AAA+) type ATPases protein. It functions as an ATP-dependent segregase and plays a role in various cellular processes, such as autophagy and endoplasmic reticulum-associa-ted degradation (ERAD). Herein, we evaluated the therapeutic potential of DBeQ on colorectal cancer cells, Caco-2 and HT-29. Our data indicated that DBeQ treatment strongly reduced the proliferative capacity, colonial growth and anchorage-independent growth of colorectal cancer cells. Moreover, DBeQ strongly increased cytochrome-c and CCAAT-enhancer-binding protein homologous protein (CHOP) protein levels and also induced cleaved caspase-3 and caspase-7 levels. Present findings suggest that DBeQ may offer a potential therapeutic effect for colorectal cancer treatment.
dc.language eng
dc.rights info:eu-repo/semantics/closedAccess
dc.title DBeQ-mediated pharmacological modulation of the retrotranslocation step of ERAD may exhibit a potent therapeutic approach against colorectal cancer
dc.type info:eu-repo/semantics/article


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account